• 1.

    Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997 Mar 28,;275(5308):1943–1947.

  • 2.

    Song MS, Salmena L, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor. Nature reviews. Molecular cell biology 2012 Apr 4,;13(5):283–296.

  • 3.

    Veleva-Rotse BO, Barnes AP. Brain patterning perturbations following PTEN loss. Front Mol Neurosci. 2014;7:35.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 4.

    Tan M, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime cancer risks in individuals with germline PTEN mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Jan 15,;18(2):400–407.

  • 5.

    Blumenthal GM, Dennis PA. PTEN hamartoma tumor syndromes. Eur J Hum Genet. 2008;16(11):1289–300.

    CAS 
    PubMed 

    Google Scholar
     

  • 6.

    Bhargava R, Au Yong KJ, Leonard N. Bannayan-Riley-Ruvalcaba syndrome: MRI neuroimaging features in a series of 7 patients. AJNR. Am J Neuroradiol. 2014;35(2):402–6.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 7.

    Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, Zheng Z, et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet. 1998;7(3):507–15.

    CAS 
    PubMed 

    Google Scholar
     

  • 8.

    Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet. 1999;8(8):1461–72.

    CAS 
    PubMed 

    Google Scholar
     

  • 9.

    Lachlan KL, Lucassen AM, Bunyan D, Temple IK. Cowden syndrome and Bannayan–Riley–Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet. 2007;44(9):579–85.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 10.

    Pilarski R, Stephens JA, Noss R, Fisher JL, Prior TW. Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan–Riley–Ruvalcaba syndrome clinical features. J Med Genet. 2011;48(8):505–12.

    CAS 
    PubMed 

    Google Scholar
     

  • 11.

    Parisi MA, Dinulos MB, Leppig KA, Sybert VP, Eng C, Hudgin L. The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome. J Med Genet. 2001;38(1):52–8.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 12.

    Buxbaum J, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J, et al. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet 2007 Jun 5,;144(4):484–91.

  • 13.

    Goffin A, Hoefsloot LH, Bosgoed EAJ, Swillen A, Fryns JP. PTEN mutation in a family with Cowden syndrome and autism. Am J Med Genet. 2001;105(6):521–4.

    CAS 
    PubMed 

    Google Scholar
     

  • 14.

    Butler MG, Dasouki MJ, Zhou X, Talebizadeh Z, Brown M, Takahashi TN, et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet. 2005;42(4):318–21.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 15.

    Kwon C, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W, et al. Pten regulates neuronal arborization and social interaction in mice. Neuron 2006 May 4,;50(3):377–388.

  • 16.

    Cupolillo D, Hoxha E, Faralli A, De Luca A, Rossi F, Tempia F, et al. Autistic-like traits and cerebellar dysfunction in Purkinje cell PTEN knock-out mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2016;41(6):1457–66.


    Google Scholar
     

  • 17.

    Mahmood U, Ahn S, Yang E, Choi M, Kim H, Regan P, et al. Dendritic spine anomalies and PTEN alterations in a mouse model of VPA-induced autism spectrum disorder. Pharmacol Res. 2018;128:110–21.

    PubMed 

    Google Scholar
     

  • 18.

    Cardoso IL, Almeida S. Genes involved in the development of autism. International Archives of Communication Disorder. 2019 Mar 27;2(1):1–9.


    Google Scholar
     

  • 19.

    Richards C, Jones C, Groves L, Moss J, Oliver C. Prevalence of autism spectrum disorder phenomenology in genetic disorders: a systematic review and meta-analysis. Lancet Psychiatry, The. 2015;2(10):909–16.


    Google Scholar
     

  • 20.

    Moss J, Howlin P. Autism spectrum disorders in genetic syndromes: implications for diagnosis, intervention and understanding the wider autism spectrum disorder population. J Intellect Disabil Res. 2009;53(10):852–73.

    CAS 
    PubMed 

    Google Scholar
     

  • 21.

    Moss J, Oliver C, Nelson L, Richards C, Hall S. Delineating the profile of autism spectrum disorder characteristics in Cornelia de Lange and fragile X syndromes. Am J Intellect Dev Disabil. 2013;118(1):55–73.

    PubMed 

    Google Scholar
     

  • 22.

    Crawford H, Moss J, Groves L, Dowlen R, Nelson L, Reid D, et al. A Behavioural assessment of social anxiety and social motivation in fragile X, Cornelia de Lange and Rubinstein-Taybi syndromes. J Autism Dev Disord. 2020;50(1):127–44.

    PubMed 

    Google Scholar
     

  • 23.

    Nelson L, Moss J, Oliver C. A longitudinal follow-up study of affect in children and adults with Cornelia de Lange syndrome. American journal on intellectual and developmental disabilities. 2014;119(3):235–52.

    PubMed 

    Google Scholar
     

  • 24.

    Clipperton-Allen AE, Page DT. Pten haploinsufficient mice show broad brain overgrowth but selective impairments in autism-relevant behavioral tests. Human molecular genetics 2014 Jul 1,;23(13):3490–3505.

  • 25.

    Sperow M, Berry RB, Bayazitov IT, Zhu G, Baker SJ, Zakharenko SS. Phosphatase and tensin homologue (PTEN) regulates synaptic plasticity independently of its effect on neuronal morphology and migration. J Physiol. 2012;590(4):777–92.

    CAS 
    PubMed 

    Google Scholar
     

  • 26.

    Wang Y, Cheng A, Mattson M. The PTEN phosphatase is essential for long-term depression of hippocampal synapses. NeuroMolecular Med. 2006;8(3):329–35.

    CAS 
    PubMed 

    Google Scholar
     

  • 27.

    Abghari FZ, Moradi Y, Akouchekian M. PTEN gene mutations in patients with macrocephaly and classic autism: a systematic review. Med J Islam Repub Iran. 2019;33:10.


    Google Scholar
     

  • 28.

    Zhou J, Parada LF. PTEN signaling in autism spectrum disorders. Curr Opin Neurobiol. 2012;22(5):873–9.

    CAS 
    PubMed 

    Google Scholar
     

  • 29.

    Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. Journal of the National Cancer Institute 2013 Nov 6,;105(21):1607–1616.

  • 30.

    Pilarski R. PTEN hamartoma tumor syndrome: a clinical overview. Cancers 2019 Jun 18,;11(6):844.

  • 31.

    Uppal S, Mistry D, Coatesworth AP. Cowden disease: a review. Int J Clin Pract. 2007;61(4):645–52.

    CAS 
    PubMed 

    Google Scholar
     

  • 32.

    Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic reviews 2015 Jan 1,;4(1):1.

  • 33.

    Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD), {date}. World Wide Web URL: https://omim.org/

  • 34.

    Hedges LV, Vevea JL. Fixed-and random-effects models in meta-analysis. Psychol Methods. 1998;3:486.


    Google Scholar
     

  • 35.

    Terrin N, Schmid CH, Lau J. In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol. 2005;58(9):894–901.

    PubMed 

    Google Scholar
     

  • 36.

    Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315:629634.


    Google Scholar
     

  • 37.

    Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000a;56(2):455–63.

    CAS 
    PubMed 

    Google Scholar
     

  • 38.

    Duval S, Tweedie R. (2000b). A nonparametric ‘trim and fill’ method of accounting for publication bias in meta-analysis. Journal of the American Statistical Society. 2000;95:89–98.


    Google Scholar
     

  • 39.

    Balci TB, Davila J, Lewis D, Boafo A, Sell E, Richer J, et al. Broad spectrum of neuropsychiatric phenotypes associated with white matter disease in PTEN hamartoma tumor syndrome. Am J Med Genet B Neuropsychiatr Genet. 2018 Jan;177(1):101–9.

    PubMed 

    Google Scholar
     

  • 40.

    Busa T, Milh M, Degardin N, Girard N, Sigaudy S, Longy M, et al. Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome. Eur J Paediatr Neurol. 2014;19(2):188–92.

    PubMed 

    Google Scholar
     

  • 41.

    Busch RM, Chapin JS, Mester J, Ferguson L, Haut JS, Frazier TW, et al. Cognitive characteristics of PTEN hamartoma tumor syndromes. Genetics Med. 2013;15(7):548–53.

    CAS 

    Google Scholar
     

  • 42.

    Busch RM, Srivastava S, Hogue O, Frazier TW, Klaas P, Hardan A, et al. Neurobehavioral phenotype of autism spectrum disorder associated with germline heterozygous mutations in PTEN. Translational psychiatry 2019 Oct 8,;9(1):253–9.

  • 43.

    Ciaccio C, Saletti V, D’Arrigo S, Esposito S, Alfei E, Moroni I, et al. Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience. European Journal of Medical Genetics 2019;62(12):103596.

  • 44.

    Frazier TW, Embacher R, Tilot AK, Koenig K, Mester J, Eng C. Molecular and phenotypic abnormalities in individuals with germline heterozygous PTEN mutations and autism. Mol Psychiatry. 2015;20(9):1132–8.

    CAS 
    PubMed 

    Google Scholar
     

  • 45.

    Hansen-Kiss E, Beinkampen S, Adler B, Frazier T, Prior T, Erdman S, et al. A retrospective chart review of the features of PTEN hamartoma tumour syndrome in children. J Med Genet. 2017 Jul;54(7):471–8.

    PubMed 

    Google Scholar
     

  • 46.

    Lynch NE, Lynch SA, McMenamin J, Webb D. Bannayan–Riley–Ruvalcaba syndrome: a cause of extreme macrocephaly and neurodevelopmental delay. Arch Dis Child. 2009;94(7):553–4.

    CAS 
    PubMed 

    Google Scholar
     

  • 47.

    Smpokou P, Fox VL, Tan W. PTEN hamartoma tumour syndrome: early tumour development in children. Arch Dis Child. 2015;100(1):34–7.

    PubMed 

    Google Scholar
     

  • 48.

    Vanderver A, Tonduti D, Kahn I, Schmidt J, Medne L, Vento J, et al. Characteristic brain magnetic resonance imaging pattern in patients with macrocephaly and PTEN mutations. American journal of medical genetics. Part A. 2014;164(3):627–33.

    CAS 

    Google Scholar
     

  • 49.

    Yehia L, Ni Y, Feng F, Seyfi M, Sadler T, Frazier TW, et al. Distinct alterations in tricarboxylic acid cycle metabolites associate with cancer and autism phenotypes in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Am J Hum Genet. 2019 Oct 3;105(4):813–21.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 50.

    Yehia L, Seyfi M, Niestroj L, Padmanabhan R, Ni Y, Frazier TW, et al. Copy number variation and clinical outcomes in patients with germline PTEN mutations. JAMA Network Open 2020 Jan 3,;3(1):e1920415.

  • 51.

    Kato K, Mizuno S, Inaba M, Fukumura S, Kurahashi N, Maruyama K, et al. Distinctive facies, macrocephaly, and developmental delay are signs of a PTEN mutation in childhood. Brain Dev. 2018;40(8):678–84.

    PubMed 

    Google Scholar
     

  • 52.

    Klein S, Sharifi-Hannauer P, Martinez-Agosto JA. Macrocephaly as a clinical indicator of genetic subtypes in autism. Autism Res. 2013;6(1):51–6.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 53.

    McBride KL, Varga EA, Pastore MT, Prior TW, Manickam K, Atkin JF, et al. Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res. 2010;3(3):137–41.

    PubMed 

    Google Scholar
     

  • 54.

    Negishi Y, Miya F, Hattori A, Johmura Y, Nakagawa M, Ando N, et al. A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly. BMC medical genetics 2017 Jan 13,;18(1):4.

  • 55.

    O’Roak B, Vives L, Fu W, Egertson JD, Stanaway IB, Phelps IG, et al. Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders. Science 2012 Dec 21,;338(6114):1619–1622.

  • 56.

    Orrico G, Buoni O, Vonella S. Novel PTEN mutations in neurodevelopmental disorders and macrocephaly. Clin Genet. 2009;75(2):195–8.

    CAS 
    PubMed 

    Google Scholar
     

  • 57.

    Saskin A, Fulginiti V, Birch AH, Trakadis Y. Prevalence of four Mendelian disorders associated with autism in 2392 affected families. J Hum Genet. 2017;62(6):657–9.

    CAS 
    PubMed 

    Google Scholar
     

  • 58.

    Varga EA, Pastore M, Prior T, Herman GE, McBride KL. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genetics in medicine : official journal of the American College of Medical Genetics. 2009;11(2):111–7.


    Google Scholar
     

  • 59.

    Wong CW, Or PM, Wang Y, Li L, Li J, Yan M, et al. Identification of a PTEN mutation with reduced protein stability, phosphatase activity, and nuclear localization in Hong Kong patients with autistic features, neurodevelopmental delays, and macrocephaly. Autism Res. 2018 Aug;11(8):1098–109.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 60.

    Yeung KS, Tso WWY, Ip JJK, Mak CCY, Leung GKC, Tsang MHY, et al. Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and/or autism. Molecular autism. 2017;8(1):66.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 61.

    Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L, et al. Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord. 1989;19(2):185.

    CAS 
    PubMed 

    Google Scholar
     

  • 62.

    Lord C, Rutter M, Le Couteur A. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24(5):659–85.

    CAS 
    PubMed 

    Google Scholar
     

  • 63.

    Wechsler D. Wechsler adult intelligence scale- third edition. 3rd ed. San Antonio, TX: Psychological corporation; 1997.


    Google Scholar
     

  • 64.

    Wechsler D. Wechsler memory scale- third edition. San Antonio, TX: Psychological corporation; 1997.


    Google Scholar
     

  • 65.

    American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Washington DC. American Psychiatric Association. 2013 May 27;70.

  • 66.

    Miyake K, Ohmura M, Takashima M, Yamanouchi S, Hashimoto T, Kobayashi K. A new test developmental screening scale—kinder infant development scale. Hum Dev Res. 1990;6:147–63.


    Google Scholar
     

  • 67.

    Ikuzawa M, Iwachidou S, Oogami R. The guide of Kyoto scale of psychological development. Kyoto Kokusai Shakaifukushi Center: The guide of Kyoto scale of psychological development. Kyoto; 2001.


    Google Scholar
     

  • 68.

    Baio J. Prevalence of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 sites, United States, 2010.


    Google Scholar
     

  • 69.

    Brugha T, Cooper SA, McManus S, Purdon S, Smith J, Scott FJ, Spiers N, Tyrer F. Estimating the prevalence of autism spectrum conditions in adults: extending the 2007 Adult psychiatric. https://pdfs semanticscholar org/efe8/77ab95ca23b45c6aa72c77ea643e67f23a08 pdf 2012 Jan 31.

  • 70.

    Skuse DH. Rethinking the nature of genetic vulnerability to autistic spectrum disorders. Trends Genet. 2007;23(8):387–95.

    CAS 
    PubMed 

    Google Scholar
     

  • 71.

    Arffa S. The relationship of intelligence to executive function and non-executive function measures in a sample of average, above average, and gifted youth. Arch Clin Neuropsychol. 2007 Nov 1;22(8):969–78.

    PubMed 

    Google Scholar
     

  • 72.

    Flint J. Annotation: behaviour phenotypes: a window on to the biology of behavior. J Child Psychol Psychiatry. 1996 May;37(4):355–67.

    CAS 
    PubMed 

    Google Scholar
     

  • 73.

    Tierney E, Nwokoro NA, Porter FD, Freund LS, Ghuman JK, Kelley RI. Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome. Am J Med Genet. 2001 Jan 15;98(2):191–200.

    CAS 
    PubMed 

    Google Scholar
     

  • 74.

    O’Brien G, editor. Behavioural phenotypes in clinical practice. Cambridge University Press; 2002 Jan 21.

  • 75.

    Hodapp RM, Dykens EM. Strengthening behavioral research on genetic mental retardation syndromes. Am J Ment Retard. 2001 Jan;106(1):4–15.

    CAS 
    PubMed 

    Google Scholar
     

  • 76.

    Waite J, Heald M, Wilde L, Woodcock K, Welham A, Adams D, et al. The importance of understanding the behavioural phenotypes of genetic syndromes associated with intellectual disability. Paediatr Child Health. 2014 Oct 1;24(10):468–72.


    Google Scholar
     

  • 77.

    Finegan J. Study of behavioral phenotypes: goals and methodological considerations. American Journal of Medical Genetics 1998 Mar 28,;81(2):148–155.

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.biomedcentral.com/)